Meta- and para-hydroxy-1-cyanophenethylamines.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004357:Drug Synergism; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009570:Nitriles / Q000138:chemical synthesis / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010627:Phenethylamines / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000633:toxicity; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects
D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D009570:Nitriles; D010276:Parasympatholytics; D010627:Phenethylamines; D013565:Sympatholytics; D013566:Sympathomimetics; D000661:Amphetamine; D009638:Norepinephrine